CD8A and neoplasm: For example, the BARTmiRNAs have been found to inhibit both CD4- and CD8-mediated immune responses toinfected cells (Albanese et al., 2016; Feederle et al., 2011; Lin et al., 2015; Tagawaet al., 2016), to foster tumor cell survival in culture (Vereide et al., 2014), and enhance tumor growth in vivo(Qiu et al., 2015).